Financials

News Ideas Discussions Technicals Seasonals

CLS_B fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Clinical Laserthermia Systems AB engages in the development and manufacture of pharmaceutical products. It offers TRANBERG, a Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors that is marketed for image-guided laser ablation and for treatment with immuno-stimulating interstitial laser thermotherapy. The company was founded by Karl-Göran Tranberg, Lars-Erik Thomas Eriksson, and Per-Hakan Henriksson on March 9, 2006 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

CLS_B has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company